Skip to content

Source filing unavailable

Q1 2026 · —
Revenue—
Net Income-$45.32MN/M vs Q1 2025N/M vs Q3 2025
EPS, diluted—

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ1 2026Q1 2025
Net Income-$45.32M-$38.33M

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Parabilis Medicines, Inc. · CIK 1657677 · Engraved from SEC EDGAR